RNASET2 and neoplasm: In keeping with the results from the previous in vivo model, RNASET2-silenced OVCAR3 cells showed a significant increase in their tumorigenic potential compared to their wild-type counterpart when challenged in nude mice, thus confirming the role played by human RNASET2 in in vivo tumor suppression.